Bakacs T - Search Results

1

Association of Baseline Tumor-Specific Neoantigens and CD8⁺ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

Kerepesi C, Abushukair HM, Ricciuti B, Nassar AH, Adib E, Alessi JV, Pecci F, Rakaee M, Fadlullah MZH, Tőkés AM, Rodig SJ, Awad MM, Tan AC, Bakacs T, Naqash AR. Kerepesi C, et al. Among authors: bakacs t. JCO Precis Oncol. 2024 Feb;8:e2300439. doi: 10.1200/PO.23.00439. JCO Precis Oncol. 2024. PMID: 38330262

2

Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.

Bakacs T, Sandig V, Kovesdi I. Bakacs T, et al. Pharmaceuticals (Basel). 2023 Feb 1;16(2):226. doi: 10.3390/ph16020226. Pharmaceuticals (Basel). 2023. PMID: 37259374 Free PMC article.

3

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections.

Bakacs T, Chumakov K, Safadi R, Kovesdi I. Bakacs T, et al. Front Immunol. 2022 Oct 6;13:1046851. doi: 10.3389/fimmu.2022.1046851. eCollection 2022. Front Immunol. 2022. PMID: 36275648 Free PMC article. No abstract available.

4

An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.

Bakacs T, Sandig V, Kovesdi I. Bakacs T, et al. Cureus. 2022 Aug 27;14(8):e28467. doi: 10.7759/cureus.28467. eCollection 2022 Aug. Cureus. 2022. PMID: 36176842 Free PMC article.

5

A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.

Bakacs T, Sandig V, Slavin S, Gumrukcu S, Hardy D, Renz W, Kovesdi I. Bakacs T, et al. Infect Disord Drug Targets. 2022;22(7):1-6. doi: 10.2174/1871526522666220419130403. Infect Disord Drug Targets. 2022. PMID: 35440336

6

Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality.

Bakacs T, Safadi R, Puskás LG, Fehér LZ, Kovesdi I. Bakacs T, et al. Cureus. 2022 Mar 1;14(3):e22750. doi: 10.7759/cureus.22750. eCollection 2022 Mar. Cureus. 2022. PMID: 35371882 Free PMC article.

7

Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report.

Bakacs T. Bakacs T. Cureus. 2021 Dec 9;13(12):e20303. doi: 10.7759/cureus.20303. eCollection 2021 Dec. Cureus. 2021. PMID: 35024256 Free PMC article.

8

Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia.

Kleef R, Bacher V, Nagy R, Reisegger P, Bakacs T. Kleef R, et al. Among authors: bakacs t. Cureus. 2021 Apr 15;13(4):e14500. doi: 10.7759/cureus.14500. Cureus. 2021. PMID: 34007753 Free PMC article.

9

Tackling cancer cell dormancy: Insights from immune models, and transplantation.

Corthay A, Bakacs T, Thangavelu G, Anderson CC. Corthay A, et al. Among authors: bakacs t. Semin Cancer Biol. 2022 Jan;78:5-16. doi: 10.1016/j.semcancer.2021.02.002. Epub 2021 Feb 11. Semin Cancer Biol. 2022. PMID: 33582171 Free article. Review.

10

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

Kleef R, Nagy R, Baierl A, Bacher V, Bojar H, McKee DL, Moss R, Thoennissen NH, Szász M, Bakacs T. Kleef R, et al. Among authors: bakacs t. Cancer Immunol Immunother. 2021 May;70(5):1393-1403. doi: 10.1007/s00262-020-02751-0. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page